Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer

Frances M. Boyle, Ian E. Smith, Joyce O'Shaughnessy, Bent Ejlertsen, Aman U. Buzdar, Pierre Fumoleau, William Gradishar, Miguel Martin, Beverly Moy, Martine Piccart-Gebhart, Kathleen I. Pritchard, Deborah Lindquist, Mayur Amonkar, Yingjie Huang, Erica Rappold, Lisa S. Williams, Jing Wang-Silvanto, Tomomi Kaneko, Dianne M. Finkelstein, Paul E. Goss

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences